🇺🇸

Index Intelligence

· daily

S&P 500 Healthcare Sector SEC Filings — May 21, 2026

The 32 filings in this S&P 500 Healthcare stream reveal a sector in transition, with strong operational performance at firms like Cirrus Logic (revenue +5.3% YoY, net income +25%) contrasting with acute distress at Dalrada Technology (revenue -44% YoY, negative equity). Capital allocation is active: News Corp authorized a $1B buyback, Broadridge raised its dividend, and Medallion Financial highlighted record earnings amid a proxy fight. M&A activity is notable with Columbia Financial/Northfield Bancorp merger and Greenland Mines' $35M acquisition. Insider trading is sparse, but the proxy contest at Medallion and withheld votes at Kingsway and HBT Financial signal governance concerns. Forward-looking catalysts include Jupiter Neurosciences' $2M offering for Parkinson's trial and NanoViricides' Ebola commentary. Overall, the sector shows bifurcation between profitable incumbents and cash-burning biotechs, with regulatory and shareholder activism risks.

8 high priority 24 medium 32 total filings
· daily

S&P 500 Technology Sector SEC Filings — May 20, 2026

The S&P 500 Technology sector is rapidly bifurcating between AI-driven hyper-growth and terrestrial restructuring. Leading the charge, **NVIDIA** delivered an extraordinary +85% YoY revenue surge to $81.6B, while **Analog Devices** rode the industrial rebound to +37% YoY growth, their highest in recent history. However, this momentum is juxtaposed against significant operational tightening: **Intuit** announced a 17% workforce reduction and up to $340M in charges, and **Aditxt** faces a liquidity crisis with cash dwindling to $269K and a ballooning $35M stockholder deficit. Capital allocation is mixed; NVIDIA raised its dividend 25x (to $0.25) and added $80B in buyback authority, while Salesforce aggressively repurchased 103M shares, distorting governance metrics. The AI infrastructure buildout is the dominant theme—NVIDIA's Data Center revenue hit $75.2B (+92% YoY)—but supply chain buildup (NVIDIA inventories +20% QoQ to $25.8B) and China revenue exclusion in guidance present notable risks. Insider activity was sparse in this batch, reducing conviction signals, but compensation-related shareholder dissent at **Iridium** (13.2% against say-on-pay) flags governance tension.

9 high priority 12 medium 21 total filings
· daily

Nasdaq 100 Stocks SEC Filings — May 20, 2026

The May 20, 2026 batch of 23 NASDAQ-100 filings reveals a sharply bifurcated market: mega-cap semiconductor leaders NVIDIA and Analog Devices post explosive growth (85% and 37% YoY revenue gains), while micro-cap clinical-stage and pre-revenue companies (Immunovant, Aditxt, Loan AI, Mosaic) show accelerating cash burns, widening losses, and deteriorating balance sheets. Period-over-period comparisons confirm an AI-driven investment cycle is compressing margins at scale—NVIDIA's R&D spend surged 58.5% YoY, Intuit's R&D rose 18.8%—despite strong top-line growth. Capital allocation trends diverge sharply: NVIDIA announced an $80B buyback and 25x dividend hike, and Starbucks retired $1.32B in debt, contrasting with cash-strapped biotechs drawing on dilutive equity offerings (Immunovant raised $544M). Insider activity shows no direct selling signals in this batch, but shareholder dissent at Iridium (13.2% against say-on-pay) and ADI's $29M severance program hint at governance and restructuring risks. The portfolio-level takeaway is a 'growth-at-a-cost' regime favoring dominant AI beneficiaries, while speculative names face a liquidity crunch.

10 high priority 13 medium 23 total filings
· daily

S&P 500 Financials Sector SEC Filings — May 20, 2026

The 50 filings from the S&P 500 Financials sector and related companies reveal a bifurcated landscape: traditional financial institutions face margin compression and rising credit losses, while asset managers and fintech innovators push into digital assets and alternative structures. Key period-over-period trends show revenue growth in select industrial and tech-adjacent financials (Analog Devices +37% YoY, CAVA +32.1%), but net income declines dominate the banking and REIT subsectors (Sachem Capital swung to -$6.1M net loss, PrimeEnergy -52.5% net income). The most critical developments include Morgan Stanley's dual crypto trust filings (Solana and Ethereum), signaling institutional crypto adoption acceleration, and the $2.25B Moderna settlement by Roivant Sciences, which creates a massive cash position for biotech deployment. Portfolio-level patterns reveal aggressive capital allocation toward share repurchases (News Corp $1B program, Salesforce $25B ASR) versus organic reinvestment, while insider activity remains muted across the sample, with no major CEO purchases or sales detected. The data suggests investors should favor asset-light, growth-oriented financial platforms over traditional lenders facing credit cycle headwinds.

25 high priority 25 medium 50 total filings
· daily

S&P 500 Consumer Staples Sector SEC Filings — May 20, 2026

The 50 filings for S&P 500 Consumer Staples on May 20, 2026, reveal a sector in transition, with a strong undercurrent of financial engineering and capital market activity, but limited direct operational data from core staples companies. Key themes include significant debt offerings and refinancings (Eli Lilly, Travel + Leisure, Wells Fargo), leadership transitions (Choice Hotels, Philip Morris), and a major M&A deal (Envirotech Vehicles/Azio AI). Period-over-period data from the limited set of consumer-related companies shows a mixed picture: Haemonetics reported a 2% revenue decline and a 42% net income drop, while CorVel showed 7% revenue growth and 17% EPS growth. The most actionable insights come from capital allocation moves, such as Eli Lilly's $8.94B debt raise to fund a pending acquisition and Travel + Leisure's $900M refinancing, signaling strategic shifts. Insider activity is sparse, but the significant shareholder dissent at Verra Mobility (33% withheld votes) and the 40% opposition to Castellum's stock plan are notable governance risk flags. The overall sentiment is neutral to mixed, with opportunities in companies executing well (CorVel) and risks in those with deteriorating fundamentals (Haemonetics, KonaTel).

25 high priority 25 medium 50 total filings
· daily

S&P 500 Industrials Sector SEC Filings — May 20, 2026

The 50 filings for S&P 500 Industrials on May 20, 2026, reveal a bifurcated landscape: strong cyclical recovery in semiconductors (Analog Devices revenue +37% YoY) contrasts with acute distress in small-cap industrials (Treasure Global net loss swing of -$3.58M YoY, Ionetix pre-revenue cash burn). The dominant themes are leadership transitions (Choice Hotels, Diamondback Energy, Schrodinger) and capital market activity (S&P Global $2B spin-off debt, Deep Fission $150M IPO, GEN Restaurant $50M shelf). Cybersecurity risk is elevated (West Pharmaceutical attack with data exfiltration). Insider activity is notably absent across filings, but capital allocation signals are mixed: dividend increases (TrustCo $0.38/sh) vs. dilutive offerings (NanoViricides $2M, WidePoint $5M). The sector shows a clear divergence between large-cap industrial strength and micro-cap fragility, with M&A integration (Santander/Webster) and IPOs providing catalyst opportunities.

24 high priority 26 medium 50 total filings
· daily

S&P 500 Energy Sector SEC Filings — May 20, 2026

The four filings in the S&P 500 Energy sector for May 20, 2026, reveal a mix of routine governance and financial distress. COPT Defense Properties and Mid-America Apartments (MAA) held annual meetings with strong shareholder support, though MAA's director Tamara Fischer faced notable opposition (91.1% for). Halliburton's meeting also passed all proposals, but director T.M. Edwards Young received significant opposition (92.1M votes against). Copley Acquisition Corp reported a net income turnaround to $1.29M from a loss of $74,699 YoY, driven by trust dividends, but cash plummeted 94% to $4,235 and expenses surged 255%. No period-over-period comparisons for revenue or margins exist as these are non-operational entities. No insider trading activity was reported. Forward-looking data is absent except for Copley's ongoing working capital loan. Capital allocation is limited to dividend income for Copley. The key theme is the divergence between stable, well-governed REITs and a cash-burning SPAC with no operating revenue.

1 high priority 3 medium 4 total filings
· daily

Dow Jones 30 Stocks SEC Filings — May 20, 2026

The 50 filings from the USA Dow Jones 30 intelligence stream, dominated by constituent and related-ecosystem companies, reveal a broadly positive but cautious economic landscape for May 2026. A clear theme is strong semiconductor demand, with Analog Devices reporting a 37% YoY revenue surge and record bookings, signaling robust industrial and communications end-markets. Concurrently, other cyclical sectors show divergent strength, including Dorian LPG's revenue more than doubling (+102% YoY) on a 75% jump in Baltic LPG rates. However, the data also exposes a two-tier market: while industrial and energy names thrive, several pre-revenue biotech and micro-cap firms are burning cash at alarming rates, with widened net losses and negative equity positions. Capital allocation trends are mixed; some firms are aggressively cutting debt (V.F. Corp reduced leverage from 4.1x to 3.1x) while others opt for stock-based interest payments (Wheeler REIT). Insider trading activity is limited in this batch, but management-led buyouts (Select Medical Holdings) and significant M&A (Red Cat's acquisition) signal conviction in specific strategic paths. Forward-looking guidance from ADI and V.F. Corp indicates continued but measured growth, while cybersecurity risks have emerged as a material operational threat, as seen in the West Pharmaceutical Services attack. The overall picture is one of uneven growth, where strong operational performance at the index level coexists with significant distress in smaller, cash-constrained entities.

27 high priority 23 medium 50 total filings
· daily

S&P 500 Consumer Discretionary Sector SEC Filings — May 20, 2026

This batch of 50 S&P 500 Consumer Discretionary filings reveals a deeply bifurcated landscape. On the positive side, **e.l.f. Beauty** reported exceptional 35% YoY revenue growth and **VF Corp** showed a strong Americas turnaround (+10% C$ ex-Dickies), while **Flex Ltd** posted 8.1% revenue growth driven by cloud infrastructure. However, these bright spots are overshadowed by widespread margin compression and deteriorating profitability. Key financial indicators show 5 companies with net losses widening by over 100% YoY and 3 companies with revenue declines. Insider activity is notably absent, with no major buying or selling signals from management across the filings. Capital allocation trends are defensive, with **Starbucks** completing $1.32B in debt buybacks and **United Fire Group** extending share repurchase authority, while dividend policies remain stable. The most critical development is **Six Flags** entering a cooperation agreement with activist investor H Partners, signaling potential operational changes in the entertainment sector. Sector-wide risks include tariff-driven cost pressures in imported goods (retail/apparel), potential recession dampening discretionary spending, and rising input costs in automotive and consumer electronics. **FG Merger II Corp**'s planned merger with modular housing company Boxabl highlights a growing SPAC trend in housing innovation.

22 high priority 28 medium 50 total filings
· daily

S&P 500 Healthcare Sector SEC Filings — May 20, 2026

The 50 filings for the S&P 500 Healthcare stream reveal a sector bifurcated between large-cap innovators executing capital market maneuvers and small/mid-cap firms facing acute financial distress. Eli Lilly and Gilead Sciences raised a combined ~$12 billion in debt, signaling a period of aggressive M&A and pipeline investment, while Roivant Sciences posted a massive $2.25 billion settlement gain but saw R&D expenses surge 37%. Conversely, several micro-cap biotechs (e.g., Klotho Neurosciences, Lifeward) reported widening net losses of 555% and 125% YoY, respectively, highlighting a cash-burn crisis. A key period-over-period trend is the divergence in revenue performance: Pacira BioSciences reported record revenue with 5-21% product growth, while Scilex Holding grew revenue 72% but saw its net loss balloon 75% due to non-cash charges. Insider activity was notably absent from the filings, but proxy fights (Pacira vs. DOMA) and shareholder dissent (Amgen's independent chairman proposal rejected 4.6:1) signal governance tensions. Capital allocation is a mixed bag, with Zoetis maintaining a stable dividend and Stryker executing a planned CFO transition, while distressed firms like Renewal Fuels and Citrine Global burn cash with no path to profitability. The overarching theme is a 'flight to quality' where only companies with strong balance sheets and clear catalysts (e.g., Roivant's brepocitinib NDA) are positioned to thrive.

21 high priority 29 medium 50 total filings
· daily

S&P 500 Technology Sector SEC Filings — May 19, 2026

The 12 filings reveal a bifurcated S&P 500 Technology landscape: established hardware leaders like Cisco are delivering strong revenue growth (12% YoY) and margin expansion, while smaller, speculative tech and biotech names show mixed signals—ranging from a major equity turnaround at AIM ImmunoTech to a widening loss at Bravo Multinational. A clear thematic driver is the AI infrastructure buildout, evidenced by Blockchain Digital Infrastructure's tripling operating cash flow and Analog Devices' strategic acquisition of Empower Semiconductor. Insider activity is sparse but notable for the lack of selling, while capital allocation trends point to reinvestment (M&A) over shareholder returns. Forward-looking catalysts are concentrated in biotech (Immunic's Phase 3 readout) and AI data center development (Blockchain Digital's 395 MW pipeline). The most actionable insights center on Cisco's operational efficiency, Immunic's upcoming trial catalyst, and the sector-wide push into power management and AI compute capacity.

4 high priority 8 medium 12 total filings
· daily

Nasdaq 100 Stocks SEC Filings — May 19, 2026

The May 19, 2026 filing batch for the NASDAQ-100 stream reveals a bifurcated market with strong operational performance at scale (Cisco) contrasting with micro-cap distress (Bravo Multinational, AIM ImmunoTech). The dominant theme is strategic portfolio repositioning: Cisco delivered a standout 12% YoY revenue beat with 35% net income growth, while Analog Devices and Maui Land & Pineapple are pursuing transformative M&A/asset sales. The XAI Madison Equity Premium Income Fund is executing a strategic sub-adviser addition to diversify its income strategy, signaling a shift toward preferred equity. However, the small-cap names show acute financial strain—Bravo Multinational's net loss widened 82% YoY, and AIM ImmunoTech only recently climbed out of a negative equity position. Insider activity is notably absent across the large-cap filers, while capital allocation actions (Kennametal's debt tender, PayPal's equity plan) suggest a focus on balance sheet management. The forward-looking catalyst calendar is anchored by Immunic's Phase 3 MS trial readout (YE 2026) and ADI's Empower Semiconductor deal closing (H2 2026), offering event-driven opportunities. Overall, the data signals a 'flight to quality' within the NASDAQ-100, where scale, cash flow, and strategic clarity are rewarded, while smaller names face existential refinancing risks.

5 high priority 7 medium 12 total filings
· daily

S&P 500 Financials Sector SEC Filings — May 19, 2026

The 50 filings for the S&P 500 Financials sector on May 19, 2026, reveal a sector bifurcated between strong revenue growth and significant margin compression. While top-line growth is evident across several sub-sectors (e.g., Energy Vault's 156% YoY revenue surge, Eagle Materials' record $2.3B revenue), profitability is under severe pressure, with net earnings declining at major firms like Home Depot (-4.2% YoY) and Eagle Materials (-9% YoY). The most critical developments include a wave of SPAC activity and business combinations (Plum Acquisition, SoftVest, Bleichroeder), signaling a potential consolidation phase, alongside notable insider actions like GitLab's chair converting all super-voting shares, which reduces governance risk. Capital allocation trends show a mix of aggressive buybacks (News Corp's $1B program) and strategic debt financing (Granite Construction's $600M notes), indicating a focus on shareholder returns and growth investment. A key portfolio-level pattern is the 'growth at all costs' theme, where companies like Thermon Group and Energy Vault are sacrificing near-term GAAP profitability for long-term market share and strategic positioning, a trend that demands careful scrutiny of cash burn rates and debt levels.

21 high priority 29 medium 50 total filings
· daily

S&P 500 Consumer Staples Sector SEC Filings — May 19, 2026

The 50 filings from the S&P 500 Consumer Staples sector reveal a sector under significant pressure, with mixed results across the board. While top-line growth is evident in some areas (Novelis +7.5% YoY, Thermon +11% YoY), profitability is being squeezed by rising costs, operational disruptions, and strategic investments. A key theme is the divergence between operational metrics and financial results, as seen in Under Armour's widening net loss (-$495.6M) despite cost-cutting, and Educational Development Corp's profit turnaround driven by a one-time asset sale. Insider activity is limited, but capital allocation is active, with major debt offerings (Pinnacle Financial $750M, Blackstone Mortgage $450M) and a significant share repurchase (HF Sinclair $100M). The most critical developments include the pending $2.2B Thermon/CECO merger, Paramount Skysdance's $51.9B acquisition financing plan for Warner Bros. Discovery, and Novelis's operational recovery from the Oswego plant fires. Portfolio-level patterns point to a sector grappling with inflation, supply chain issues, and the need for strategic transformation, creating a landscape of both significant risks and selective opportunities for investors.

18 high priority 32 medium 50 total filings
· daily

S&P 500 Industrials Sector SEC Filings — May 19, 2026

The 50 filings reveal a mixed landscape for S&P 500 Industrials, with several companies showing revenue declines and margin compression, while others exhibit strong turnaround stories or strategic moves. Notable period-over-period trends include revenue drops at Red Robin (-3.6% YoY), Educational Development Corp (-33% YoY), and SunPower (-7.2% YoY), contrasted with Home Depot's 4.8% YoY sales growth. Insider activity is limited, but significant capital allocation actions include FB Bancorp's 10% share buyback and Blackstone Mortgage Trust's $450M debt issuance. Forward-looking statements highlight Einride's SPAC merger (June 4 vote) and Iridex's positive cash flow guidance. The most critical developments are Bitcoin Depot's Nasdaq delisting due to bankruptcy, CNS Pharmaceuticals' dilutive S-3 filing, and Oramed's swing to profitability on non-operating income. Portfolio-level themes include margin pressure in consumer-facing industrials, increased leverage in real estate, and a shift toward AI and quantum computing investments.

20 high priority 30 medium 50 total filings
· daily

S&P 500 Energy Sector SEC Filings — May 19, 2026

The four S&P 500 Energy filings reveal a sector dominated by routine corporate governance events—annual meetings and shareholder votes—with limited operational or strategic surprises. However, enriched data uncovers critical undercurrents: Baker Hughes faces notable shareholder dissent on compensation (7.2% against say-on-pay) and director elections, signaling governance friction despite overall approval. Ultrapar Holdings presents a mixed financial picture with top-line revenue growth of 6.6% YoY but declining gross profit (-3.4% YoY), rising debt (+44.6% YoY), and a loss from discontinued operations, pointing to operational strain and balance sheet risk. Kinder Morgan and SunCoke Energy show strong shareholder support with minimal dissent, reflecting stable governance. The key portfolio-level pattern is a divergence between governance stability (KMI, SUN) and emerging governance/operational risks (BKR, UGP), suggesting selective investor caution. No forward-looking guidance, insider trading, or capital allocation changes were reported, limiting actionable catalysts but highlighting the need to monitor Ultrapar's debt trajectory and Baker Hughes' compensation dynamics.

1 high priority 3 medium 4 total filings
· daily

Dow Jones 30 Stocks SEC Filings — May 19, 2026

The May 19, 2026 filing batch for the Dow 30 stream reveals a market bifurcated between resilient consumer-facing giants and deeply distressed smaller entities. The dominant theme is margin compression, with Home Depot reporting a 100 bps operating margin decline despite 4.8% revenue growth, while CAVA Group's 32.2% revenue surge was overshadowed by a net income drop. A significant M&A wave is cresting, with the $2.2B Publicis/LiveRamp deal and Thermon/CECO merger creating actionable catalysts, though Two Harbors' adjourned shareholder vote signals deal execution risk. The most alarming trend is the cash burn across the portfolio: Energy Vault's cash used in operations surged 20x to $53.8M, Sono Group posted negative equity, and Ehave's losses widened 31.6% with only $2,183 in revenue. Insider activity is sparse but telling, with no major insider buying detected, while the restatement at Driven Brands ($77M cumulative EBITDA hit) and the PFIC warning from 36Kr represent significant governance and tax risks. The opportunity set lies in the M&A arbitrage (LiveRamp at $38.50/sh) and the turnaround plays at Novelis (Oswego restart) and CAVA (raised guidance), but the overall tone is cautious, favoring quality and liquidity.

11 high priority 39 medium 50 total filings
· daily

S&P 500 Consumer Discretionary Sector SEC Filings — May 19, 2026

The 50 filings for the S&P 500 Consumer Discretionary stream on May 19, 2026, reveal a sector bifurcated between strong top-line growth and margin compression. Home Depot's Q1 results exemplify this, with sales up 4.8% YoY but net earnings down 4.2% and operating margins contracting 100 bps, leading to a reaffirmed but cautious full-year guidance. The most significant capital allocation signal comes from HF Sinclair Corp, which executed its 21st share repurchase from a single holder, totaling $717M of a $1B program, indicating a strong commitment to returning capital. M&A activity is concentrated in the financial and energy sectors, with Bank First Corp's $202.9M all-stock acquisition of PSB Holdings and the proposed business combination for Permian Basin Royalty Trust, both carrying execution risk. Insider activity is notably absent across consumer discretionary names, but several SPACs (FortuneX, FG Merger III) are actively seeking targets, creating a pipeline of potential future transactions. The most critical risk is the accounting restatement at BestGofer Inc., which revealed a $78,754 goodwill impairment and a 12x increase in net loss, a severe red flag for micro-cap governance. Overall, the sector shows resilience in demand but faces profitability headwinds, with investors favoring companies that demonstrate clear capital return policies and operational efficiency.

15 high priority 35 medium 50 total filings
· daily

S&P 500 Healthcare Sector SEC Filings — May 19, 2026

The 42 filings for the S&P 500 Healthcare sector reveal a sector in transition, with significant capital market activity (IPOs, SPACs, debt offerings) and strategic repositioning (M&A, name changes, C-suite transitions) overshadowing operational results. Key period-over-period trends from the limited operational data available show a stark divergence: Cisco's 12% revenue growth and 35% net income surge contrast sharply with BioForce Nanosciences' continued revenue-less losses and Parabilis Medicines' widening net losses of $145.9M. The most critical developments include Parabilis Medicines' IPO filing with a concurrent $75M Regeneron private placement, signaling strong strategic interest in its pipeline, and Humana's $1.5B P-Caps issuance, a complex capital management move. Insider activity is notably absent across the healthcare filings, but the high volume of capital allocation events (debt offerings, buybacks, IPO filings) suggests a sector actively managing its balance sheet and growth trajectory. Portfolio-level patterns indicate a focus on liquidity management (TechPrecision's credit extension, Humana's P-Caps) and a cautious but present appetite for growth capital (Parabilis IPO, Energy Transition SPAC IPO).

13 high priority 29 medium 42 total filings
· daily

S&P 500 Technology Sector SEC Filings — May 18, 2026

The 17 filings reveal a mixed landscape within the S&P 500 Technology sector and broader market. Key themes include significant insider buying at Genco Shipping, a large jury verdict against Acadia Healthcare, and a forward stock split for the abrdn Palladium ETF. Period-over-period trends show Genco's dramatic turnaround to profitability, while Madison Technologies remains revenue-less with worsening cash burn. Insider activity is sparse but notable at Genco, where management is actively opposing a tender offer. Capital allocation varies, with Genco increasing dividends and Cottonwood raising preferred equity. Forward-looking data highlights upcoming catalysts such as ImmunityBio's FDA engagement for BCG approval and RideNow's potential credit facility expansion. Overall, the digest points to selective opportunities in shipping and biotech, while caution is warranted for cash-burning microcaps and litigation risks.

6 high priority 11 medium 17 total filings